By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Leica Microsystems and Abbott today announced a deal to develop a fully automated fluorescent in situ hybridization solution for HER2 testing.

Under the terms of the deal, Abbott will supply FISH probes targeting the HER2 gene locus, which will be used to develop the automated HER2 FISH test on Leica's BOND automated advanced staining platform.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.